City

Jerusalem (1)

Condition

Schizophrenia and Schizoaffective Disorder (2)

Tardive Dyskinesia (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

n/a (1)

phase 3 (1)

Sponsor

Herzog Hospital (1)

Otsuka Pharmaceutical Development & Commercialization, Inc. (1)

Collaborator

Otsuka America Pharmaceutical (1)

Intervention

aripiprazole (1)

d-serine (1)

placebo (1)

Study Documents

Intervention Type

dietary supplement (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

schizophrenia and schizoaffective disorder

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Schizophrenia and Schizoaffective Disorder, Tardive Dyskinesia Trial in Jerusalem (D-serine, Placebo)

Unknown status

Schizophrenia and Schizoaffective Disorder
Tardive Dyskinesia

D-serine
Placebo

Jerusalem, Israel

Herzog Hospital

Oct 9, 2018

Schizophrenia and Schizoaffective Disorder Trial (Aripiprazole)

Completed

Schizophrenia and Schizoaffective Disorder

Aripiprazole

(no location specified)

Nov 7, 2013